Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer. - Maruyama Y; Saito M; Nakajima S; Saito K; Suzuki H; Kanoda R; Okayama H; Hanayama H; Sakamoto W; Saze Z; Momma T; Mimura K; et al. (Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2025)